Metropolis On Q2 Growth: Strong Volumes, Higher Productivity Support Margins Despite No Price Hikes

Metropolis Healthcare reported a healthy Q2 performance, driven by strong volume growth and improved productivity. Managing Director C Surendran highlighted the company’s margin expansion, supported by higher productivity, while noting that Metropolis continues to deliver strong growth without price hikes. The company’s B2C business outperformed its B2B segment, reflecting healthy demand trends. Surendran also discussed the company’s growth momentum and operational performance, underscoring the contribution of volumes and productivity to its quarterly results.